Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 European Medicines Agency: leave the UK but remain the same.

Literature DB >> 27609795

European Medicines Agency: leave the UK but remain the same.

Livio Garattini¹, Alessandro Curto².

Abstract

Mesh：

Year: 2016 PMID： 27609795 PMCID： PMC5017522 DOI： 10.1177/0141076816663559

Source DB: PubMed Journal: J R Soc Med ISSN： 0141-0768 Impact factor: 5.344

× No keyword cloud information.

7 in total

Review 1. Modeling in pharmacoeconomic studies: funding sources and outcomes.

Authors: Livio Garattini; Daniela Koleva; Gianluigi Casadei
Journal: Int J Technol Assess Health Care Date: 2010-07 Impact factor: 2.188

2. Pharmaceutical Price Schemes in Europe: Time for a 'Continental' One?

Authors: Livio Garattini; Alessandro Curto; Nick Freemantle
Journal: Pharmacoeconomics Date: 2016-05 Impact factor: 4.981

3. Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis.

Authors: Livio Garattini; Dante Cornago; Paola De Compadri
Journal: Health Policy Date: 2006-11-27 Impact factor: 2.980

4. Could co-payments on drugs help to make EU health care systems less open to political influence?

Authors: Livio Garattini; Katelijne van de Vooren
Journal: Eur J Health Econ Date: 2013-10

5. The European Medicines Agency is still too close to industry.

Authors: Silvio Garattini
Journal: BMJ Date: 2016-05-06

6. Designing "Real-World" trials to meet the needs of health policy makers at marketing authorization.

Authors: Melanie Calvert; John Wood; Nick Freemantle
Journal: J Clin Epidemiol Date: 2011-03-31 Impact factor: 6.437

7. From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients.

Authors: H-G Eichler; L G Baird; R Barker; B Bloechl-Daum; F Børlum-Kristensen; J Brown; R Chua; S Del Signore; U Dugan; J Ferguson; S Garner; W Goettsch; J Haigh; P Honig; A Hoos; P Huckle; T Kondo; Y Le Cam; H Leufkens; R Lim; C Longson; M Lumpkin; J Maraganore; B O'Rourke; K Oye; E Pezalla; F Pignatti; J Raine; G Rasi; T Salmonson; D Samaha; S Schneeweiss; P D Siviero; M Skinner; J R Teagarden; T Tominaga; M R Trusheim; S Tunis; T F Unger; S Vamvakas; G Hirsch
Journal: Clin Pharmacol Ther Date: 2015-02-04 Impact factor: 6.875

7 in total

6 in total

1. HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

Authors: Livio Garattini; Anna Padula
Journal: Eur J Health Econ Date: 2020-02

2. Market approval for drugs in the EU: time to change direction?

Authors: Alessandro Curto; Katelijne van de Vooren; Livio Garattini
Journal: Eur J Health Econ Date: 2017-11

3. Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?

Authors: Livio Garattini; Anna Padula
Journal: J R Soc Med Date: 2017-01-24 Impact factor: 5.344